PapersPMID:22773702
Curcumin extract for prevention of type 2 diabetes.
- 01 · finding
- 1
- 02 · compound
- 1
- 03 · endpoint
- 1
- 04 · null
- 0
curcuminWhat moved
1 findingHow to read these marks →“The means of HOMA-IR of the curcumin-treated group were lower than those of placebo group at all follow-up visits (3, 6, and 9 months).”
Quoted verbatim from Curcumin extract for prevention of type 2 diabetes. - Study
- RCT
- Duration
- 9 months
- Interests
- Industry funded
- Dose studied
- curcumin extract capsules, 250 mg curcuminoids per capsule, 6 capsules/day (1500 mg/day) for 9 months
- Population
- adults with prediabetes
Study record
- Read under
- curcumin
- Design
- randomised controlled trial
- Species
- human
- Population
- adults aged >=35 years with prediabetes (ADA criteria)
- Participants
- 237
- Comparator
- placebo
- Duration
- 270 days
- Endpoints measured
- 11
- Record
- extracted
- Readings recorded
- 2